We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers: Keep Information Flow on Off-Label Uses Open, Fact Based
Drugmakers: Keep Information Flow on Off-Label Uses Open, Fact Based
April 6, 2012
Biopharma companies should be allowed to provide factual, non-misleading information about their products’ uses in an open, scientific dialogue whether uses are off-label or not, drugmakers are telling the FDA.